NEW YORK — Higher costs associated with its Sally Hansen products put a wrinkle in Del Laboratories’ third-quarter financial results.
For the three months ended Sept. 30, the Uniondale, N.Y.-based cosmetics maker said profits slid by 8.7 percent to $4.7 million, or 48 cents a diluted share, compared with $5.1 million, or 54 cents, in the same period last year. The company said the quarterly results were adversely impacted by higher advertising and display costs in support of its new Sally Hansen Healing Beauty product line of skin care makeup and its core Sally Hansen franchise.
A Stella McCartney sketch of a custom dress made from protein-based silk in partnership with biotech lab Bolt Threads. The dress will be displayed at The Museum of Modern Art's upcoming design exhibition, "Items: Is Fashion Modern?"